Purchase Order 1232SA26P0016
Award Date 1/20/26
Potential Completion Date 1/30/26
Potential Value $11K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Kerrville, TX 78028, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Illumina, Inc., a San Diego-based biotechnology company specializing in genetic sequencing and genomic analysis technologies, received a contract award on March 20, 2018, through a Blanket Purchase Agreement (BPA) call with a civilian federal agency's Southeast Area office. The contract, valued at $8,256.23 with a firm fixed price structure, covers the procurement of Nextera XT DNA Library Preparation Kit, Index Kit, High Output Kit, and PhiX Control Kit—specialized reagent kits essential for...
- Illumina, Inc., a San Diego-based biotechnology company specializing in genomic sequencing technologies, was awarded a $35,052.16 firm fixed price call under a Blanket Purchase Agreement (BPA) on December 15, 2015, for NextEra XT DNA Sample Kits. This contract, which carried no set-aside designation, reflected Illumina's specialized capabilities in providing advanced genomic sequencing consumables and reagents. The award was funded by a civilian federal agency (Plains Area) with a completion...
- Illumina, Inc., a San Diego-based biotechnology company specializing in genomic sequencing and analysis technologies, was awarded a Purchase Order contract by the Office of Administrative Services Procurement Management Branch on April 7, 2015, with a ceiling value of $29,529.80 and an ultimate completion date of April 30, 2016. This Firm Fixed Price contract, which carries no set-aside designation, is to be performed in Athens, Georgia. As a leading provider of DNA and RNA sequencing...
- Illumina, Inc. was awarded a contract valued at $421,838.22 by the Office of Administrative Services Procurement Management Branch to supply Illumina sequencing equipment and related products for the Eastern Laboratory. This contract is executed as a call order under the existing Blanket Purchase Agreement AG-32SC-B-14-0005 on a firm fixed-price basis with no set-aside designation. The award was made on January 9, 2019, with an ultimate completion date of September 9, 2019, and performance is...
- This firm fixed-price purchase order was awarded by the Northeast Area of a civilian federal agency to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The $11,166.80 contract is for the relocation of two Illumina instruments and associated maintenance services. No set-aside designation was used. Illumina holds several Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs, including a $231,165 Blanket Purchase Agreement and a...
- Illumina, Inc. has been awarded a delivery order valued at $34,745.64 for the renewal of service contract on Illumina Tecan equipment. This firm fixed-price contract, awarded on September 10, 2025, will continue through September 9, 2026, and is being funded by a civilian federal agency within the Northeast Area. The work will be performed at a facility in Calverton, Maryland. The contract does not utilize any set-aside designation, reflecting Illumina's specialized capabilities in providing...
- Illumina, Inc. was awarded a delivery order valued at $17,333.02 by a civilian Northeast Area federal agency on August 9, 2021, with an ultimate completion date of September 9, 2021. This contract utilizes a firm fixed-price structure and does not employ a set-aside designation. The delivery order, referencing BPA priced items from quote number 4367642 submitted by Sam Hester, procures NextSeq 500/550 Kit V2.5 for 150 cycles (catalog number 20024907) at a quantity of four units at $2,954 each...
- Illumina, Inc., a biotechnology firm headquartered in San Diego, California, was awarded a Blanket Purchase Agreement (BPA) call valued at $144,955.20 for a NextSeq 500 High Output sequencing instrument. The contract, issued on March 9, 2015, by a civilian federal agency within the Plains Area, utilized firm fixed pricing and carried an ultimate completion date of September 9, 2019. No small business set-aside was applied to this award, reflecting Illumina's specialized technological...
- Illumina, Inc. was awarded a delivery order contract by the Plains Area federal agency on May 19, 2021, for the procurement of a NextSeq 2000 Sequencing System. This firm fixed-price delivery order, with a ceiling value of $236,845, represents a specialized acquisition of advanced genomic sequencing instrumentation for placement at Clay Center, Nebraska. The contract was awarded without set-aside designation, reflecting Illumina's established position as a primary provider of genetic...
- Illumina, Inc., a San Diego-based biotechnology company specializing in genetic sequencing and genomic analysis technologies, was awarded a BPA (Blanket Purchase Agreement) call contract by the Plains Area, a civilian division of a federal agency, on September 16, 2018. The contract, valued at $25,769.57 with a firm fixed price structure, covers sequencing supplies and is scheduled for completion by October 31, 2018. This award was made without a set-aside designation, reflecting Illumina's...